We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLIN icon
4726
Bridgeline Digital
BLIN
$14.6M
$76K ﹤0.01%
39,834
EVGN icon
4727
Evogene
EVGN
$5.7M
$76K ﹤0.01%
5,901
INKT icon
4728
MiNK Therapeutics
INKT
$52.3M
$76K ﹤0.01%
3,390
+1,032
+44% +$31K
NAVB
4729
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$76K ﹤0.01%
97,206
ARTL icon
4730
Artelo Biosciences
ARTL
$2.68M
$75K ﹤0.01%
622
+19
+3% +$2.18K
GP
4731
GreenPower Motor Co
GP
$10.5M
$75K ﹤0.01%
1,108
XELB icon
4732
Xcel Brands
XELB
$7.27M
$75K ﹤0.01%
5,035
ACOR
4733
DELISTED
Acorda Therapeutics
ACOR
$75K ﹤0.01%
2,336
SQFT icon
4734
Presidio Property Trust
SQFT
$74K ﹤0.01%
2,018
+874
+76% +$32.9K
KA
4735
DELISTED
Kineta, Inc. Common Stock
KA
$74K ﹤0.01%
7,127
MRAI
4736
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
$74K ﹤0.01%
10,284
+3,632
+55% +$33.1K
ALOY
4737
REalloys Inc
ALOY
$599M
$73K ﹤0.01%
+6,817
New +$58.1K
WORX
4738
DELISTED
SCWORX CORP NEW
WORX
$73K ﹤0.01%
290
TRT
4739
Trio-Tech International
TRT
$101M
$72K ﹤0.01%
+20,228
New +$74.4K
VRNA
4740
DELISTED
Verona Pharma
VRNA
$72K ﹤0.01%
14,437
+1,164
+9% +$6.77K
ILLM
4741
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$72K ﹤0.01%
23,024
+9,755
+74% +$28K
QTEK
4742
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$72K ﹤0.01%
22,514
CALC icon
4743
CalciMedica
CALC
$15.8M
$70K ﹤0.01%
4,118
MAAS
4744
Maase Inc
MAAS
$7.87B
$70K ﹤0.01%
205
AHPI
4745
DELISTED
Allied Healthcare Products
AHPI
$70K ﹤0.01%
21,703
SWAG icon
4746
Stran & Co
SWAG
$36.7M
$69K ﹤0.01%
39,739
+16,835
+74% +$42.2K
EBON icon
4747
Ebang International Holdings
EBON
$12.3M
$68K ﹤0.01%
1,981
PYPD icon
4748
PolyPid
PYPD
$82.3M
$68K ﹤0.01%
418
NTBL
4749
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$68K ﹤0.01%
1,152
BTTX
4750
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$68K ﹤0.01%
+34,847
New +$120K

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.